Leap Therapeutics welcomes Dr. Richard Schilsky to its Board of Directors
– USA, MA – Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the appointment of Dr.…